- Home
- ACTG vs ZVRA Comparison
ACTG vs ZVRA Comparison
Compare ACTG & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACTG
- ZVRA
- Stock Information
- Founded
- ACTG 1993
- ZVRA 2006
- Country
- ACTG United States
- ZVRA United States
- Employees
- ACTG N/A
- ZVRA N/A
- Industry
- ACTG Multi-Sector Companies
- ZVRA Biotechnology: Pharmaceutical Preparations
- Sector
- ACTG Miscellaneous
- ZVRA Health Care
- Exchange
- ACTG Nasdaq
- ZVRA Nasdaq
- Market Cap
- ACTG 387.5M
- ZVRA 381.0M
- IPO Year
- ACTG 1996
- ZVRA 2015
- Fundamental
- Price
- ACTG $2.89
- ZVRA $7.15
- Analyst Decision
- ACTG
- ZVRA Strong Buy
- Analyst Count
- ACTG 0
- ZVRA 8
- Target Price
- ACTG N/A
- ZVRA $22.29
- AVG Volume (30 Days)
- ACTG 376.1K
- ZVRA 542.5K
- Earning Date
- ACTG 05-08-2025
- ZVRA 05-07-2025
- Dividend Yield
- ACTG N/A
- ZVRA N/A
- EPS Growth
- ACTG N/A
- ZVRA N/A
- EPS
- ACTG N/A
- ZVRA N/A
- Revenue
- ACTG $122,312,000.00
- ZVRA $23,612,000.00
- Revenue This Year
- ACTG $86.80
- ZVRA $267.44
- Revenue Next Year
- ACTG N/A
- ZVRA $90.10
- P/E Ratio
- ACTG N/A
- ZVRA N/A
- Revenue Growth
- ACTG N/A
- ZVRA N/A
- 52 Week Low
- ACTG $2.70
- ZVRA $4.20
- 52 Week High
- ACTG $5.74
- ZVRA $9.76
- Technical
- Relative Strength Index (RSI)
- ACTG 31.25
- ZVRA 45.68
- Support Level
- ACTG $2.70
- ZVRA $6.77
- Resistance Level
- ACTG $3.14
- ZVRA $7.22
- Average True Range (ATR)
- ACTG 0.20
- ZVRA 0.45
- MACD
- ACTG 0.02
- ZVRA -0.00
- Stochastic Oscillator
- ACTG 26.03
- ZVRA 61.74
About ACTG Acacia Research Corporation (Acacia Tech)
Acacia Research Corp is focused on acquiring and operating businesses across the industrial, energy, and technology sectors where it believes it can leverage its expertise, significant capital base, and deep industry relationships to drive value. Acacia evaluates opportunities based on the attractiveness of the underlying cash flows, without regard to a specific investment horizon. Acacia operates its businesses based on three key principles of people, process, and performance and has built a management team with demonstrated expertise in research, transactions and execution, and operations and management.
About ZVRA Zevra Therapeutics Inc.
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.